Cohance Lifesciences Limited has informed the Exchange about Schedule of meet
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cohance Lifesciences has scheduled a conference call for investors and analysts on Wednesday, May 28, 2025 at 6:15 pm IST. The call will discuss the company's audited financial results for Q4 FY25 and full year FY25, which will be considered and declared on the same day. Senior management participating includes Executive Chairman Vivek Sharma, Managing Director Dr. V Prasada Raju, CEO Dr. Sudhir Kumar Singh, CFO Himanshu Agarwal, and Head of IR Cyndrella Carvalho. The session will begin with a management discussion on results, followed by an interactive Q&A. Dial-in numbers have been provided for participants in India, Singapore, Hong Kong, USA, and UK.
This is a routine pre-results announcement and does not, by itself, move the stock. It signals that Q4 and FY25 audited results are due on May 28, 2025, giving investors a near-term catalyst to watch for revenue, margin, and guidance commentary from management.